Background-Brugada syndrome, characterized by ST-segment elevation in the right precordial ECG leads and the development of life-threatening ventricular arrhythmias, has been associated with mutations in 6 different genes. We identify and characterize a mutation in a new gene. Methods and Results-A 64-year-old white male displayed a type 1 ST-segment elevation in V1 and V2 during procainamide challenge. Polymerase chain reaction-based direct sequencing was performed using a candidate gene approach. A missense mutation (L10P) was detected in exon 1 of SCN3B, the ␤3 subunit of the cardiac sodium channel, but not in any other gene known to be associated with Brugada syndrome or in 296 controls. Wild-type (WT) and mutant genes were expressed in TSA201 cells and studied using whole-cell patch-clamp techniques. Coexpression of SCN5A/WTϩSCN1B/WTϩSCN3B/L10P resulted in an 82.6% decrease in peak sodium current density, accelerated inactivation, slowed reactivation, and a Ϫ9.6-mV shift of half-inactivation voltage compared with SCN5A/WTϩSCN1B/ WTϩSCN3B/WT. Confocal microscopy revealed that SCN5A/WT channels tagged with green fluorescent protein are localized to the cell surface when coexpressed with WT SCN1B and SCN3B but remain trapped in intracellular organelles when coexpressed with SCN1B/WT and SCN3B/L10P. Western blot analysis confirmed the presence of Na V ␤3 in human ventricular myocardium. Conclusions-Our results provide support for the hypothesis that mutations in SCN3B can lead to loss of transport and functional expression of the hNa v 1.5 protein, leading to reduction in sodium channel current and clinical manifestation of a Brugada phenotype. (Circ Cardiovasc Genet. 2009;2:270-278.) 
B rugada syndrome (BrS) is a cardiac channelopathy characterized by ST-segment elevation or the appearance of accentuated J waves in the right precordial leads (V1 to V3) of the ECG and the development of life-threatening polymorphic ventricular tachycardia. The ECG characteristics of the BrS are dynamic and often concealed but can be unmasked by potent sodium channel blockers. 1, 2 
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BrS has been associated with mutations in 6 different genes. Mutations in SCN5A (Na v 1.5, BrS1) have been reported in 11% to 28% of BrS probands, CACNA1C (Ca v 1.2, BrS3) in 6.7%, CACNB2b (Ca v ß2b, BrS4) in 4.8% and mutations in glycerol-3-phophate dehydrogenase 1-like enzyme gene (GPD1L, BrS2), ␤ 1 -subunit of sodium channel (SCN1B, BrS5), and MiRP2 (KCNE3; BrS6) are much more rare. [3] [4] [5] [6] [7] [8] These genetic defects lead to development of BrS secondary to either a loss of function of sodium (I Na ) or L-type calcium (I Ca ) channel current, or a gain of function of transient outward current (I to ). Thus, Ϸ72% of BrS probands remain genotype negative. Here, we report the identification of another gene associated with the BrS phenotype caused by loss of function of I Na secondary to a mutation in the ß3-subunit of the cardiac sodium channel, encoded by SCN3B.
an ABI PRISM 3100-Avant Automatic DNA sequencer (Applied Biosystem, Foster City, Calif). The sequence primers of SCN3B are shown in Table 1 (reference sequence, NM_018400). One hundred twenty individuals, matched by race and ethnic background, with no history of cardiac arrhythmias were used as controls.
Site-Directed Mutagenesis and Transfection of the TSA201 Cell Line
For patch-clamp study, site-directed mutagenesis was performed with QuikChange (Stratagene, La Jolla, Calif) on full-length human wild-type (WT) and mutant SCN3B cDNA cloned in pIRES2-DsRed-Express (RFP) vector, the WT SCN1B cloned in pIRES2-AcGFP1 vector, and the WT SCN5A cloned in pcDNA3.1. SCN3B was a gift from Dr Takashi Tokino (Japan). In the case of trafficking studies, human WT SCN5A cDNA cloned in pcDNA3.1 with fusion green fluorescent protein (GFP) at the C-terminus was coexpressed with, the WT SCN1B cloned in pRC-CMV, and WT and mutated SCN3B cloned in pIRES2 with RFP. The mutated plasmid was sequenced to ensure the presence of the mutation without spurious substitutions.
Sodium channels were expressed in a modified human embryonic kidney cell line, TSA201. Briefly, transient transfection using fugene6 (Roche Diagnostics, Indianapolis, Ind) was carried out with SCN5A, SCN1B, and SCN3B (WT or mutant) with a molar ratio of 1:1:1. The cells were grown in GIBCO Dulbecco's minimum essential medium (No. 10566, Gibco, Invitrogen, Carlsbad, Calif) with FBS (No. 16000) and antibiotics (No. 15140) on polylysine coated 35-mm culture dishes (Cellϩ, Sarstedt, Newton, NC). Cells were placed in a 5% CO 2 incubator at 37°C for 24 to 48 hours before patch-clamp study. It is noteworthy that previous studies have demonstrated that no endogenous SCN5A, and its ␤-subunits are expressed in the TSA201 cell line. 9
Patch-Clamp Method
Membrane currents were measured using whole-cell patch-clamp techniques. All recordings were obtained at room temperature (20°C to 22°C) using an Axopatch 200B amplifier equipped with a CV-201A head stage (Axon Instruments Inc, Foster City, Calif). Measurements were started 10 minutes after obtaining the whole-cell configuration to allow the current to stabilize. The holding potential was maintained at Ϫ120 mV. Macroscopic whole cell Na ϩ current was recorded by using bath solution perfusion containing (in millimoles per liter) 130 NaCl, 5 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 2.8 sodium acetate, 10 HEPES, 10 glucose (pH 7.3 with NaOH). Tetraethylammonium chloride (5 mmol/L) was added to the buffer to block TEA-sensitive native currents. Patch pipettes were fabricated from 1.5-mm OD borosilicate glass capillaries (Fisher Scientific, Pittsburgh, Pa). They were pulled using a gravity puller (Model PP-830, Narishige Corp, Japan) to obtain resistances between 0.8 and 2.8 mol/L ⍀ when filled with a solution containing (in mmol/L) 5 NaCl, 5 KCl, 130 CsF, 1.0 MgCl 2 , 5 EGTA, 10 HEPES, and 5 TEA (pH 7.2 with CsOH). Currents were filtered with a 4 pole Bessel filter at 5 kHz and digitized at 50 kHz. Series resistance was electronically compensated at Ϸ80%. I Na was elicited by depolarizing pulses ranging from Ϫ90 to ϩ30 mV in 5-mV increments with a holding potential of Ϫ120 mV. Peak currents were measured and I Na densities (pA/pF) were obtained by dividing the peak I Na by the cell capacitance obtained. Activation properties were determined from I/V relationships by normalizing peak I Na to driving force and maximal I Na , and plotting normalized conductance versus Vm. Voltage-dependence of steady-state inactivation was obtained by plotting the normalized peak current (40-ms test pulse to Ϫ20 mV after a 1000-ms conditioning pulse from Ϫ140 to Ϫ60 mV with the holding potential of Ϫ120 mV) versus Vm. The activation and steady-state inactivation curves were fitted to the Boltzmann equation, I/I max ϭ1/(1ϩexp((VϪV 1/2 )/k), to determine the membrane potential for half-maximal inactivation V 1/2 and the slope factor k. Pulses for recovery from inactivation were of 20-ms duration. Peak current elicited during the second pulse was normalized to the value obtained during the initial test pulse. It was analyzed by fitting data to a double exponential function:
, where A f and A s are the fractions of fast and slow inactivating components, respectively, and f and s are their time constants.
All data acquisition and analysis were performed using pCLAMP version 9.2 (Axon Instruments), Excel (Microsoft, Redmond, Wash), and Origin 7.5 (Microcal Software, Northampton, Mass).
Localization of Na ؉ Channels
We assessed channel trafficking using Na ϩ channels ␣-subunit (SCN5A) tagged with GFP. Confocal microscopy was used to localize the channels and identify trafficking defects. Briefly, cells were grown on polylysine-coated glass bottom 35-mm culture dishes and studied 48 hours posttransfection. Experiments were performed on an Olympus FluoView laser-scanning confocal microscope (Olympus, Orangeburg, NY) and images were acquired with Fluo-View acquisition software program on a personal computer. GFPlabeled cells were analyzed in the xyz configuration. An argon laser provided the excitation light at 488 nm and the emission light was collected at 520 nm in photomultiplier tube 1. Transmission image was acquired in photomultiplier tube 2. Fluorescence signals were collected with either a 40ϫ or a 60ϫ oil-immersion objective lens. xy frame was set to 512ϫ512 pixels and laser intensity was set to 6% power. The z axis was changed in Ϸ0.50-m increments by computer control through the entire volume of the cell. To quantify the membrane expression of Na v 1.5 fluorescence intensity at the plasma membrane region (2 m) and the entire cell area in the middle xy image of the z series stack was measured and the ratio of peripheral to total cell area fluorescence was calculated. Analysis of GFP-labeled cells was performed using both FluoView and Image J software.
Western Blot Analysis
Membrane proteins (50 g/lane, except for TSA201-SCN3B 0.5 g/lane) were run on 5% to 15% gradient linear SDS-PAGE. BIO-RAD 161 to 0374 Precision Plus Protein Dual Color Standards 10 /lane was used as a molecular marker reference. Rabbit anti-human SCN3B polyclonal antibody at 1:500 (ab48552, Abcam, Cambridge, Mass) was used to detect bands in membrane proteins from untransfected TSA201 cells (negative control), SCN3B transfected TSA201 cells (positive control), and from 2 human left ventricular samples.
Statistical Analysis
Data are presented as meanϮSEM. A 2-tailed Student t test was used for statistical comparison of 2 groups and ANOVA coupled with Student-Newman-Keuls test for comparison of 3 or more groups (SigmaStat, Jandel Scientific Software, San Rafael, Calif). Differences were considered statistically significant at a value of PϽ0.05.
Results

Index Case
The study was approved by the regional institutional review board. The proband, a 64-year old white man (German, Swedish, and Native American descent), presented with a resting ECG displaying a slight ST-segment elevation and negative T wave in V1 suggestive, but not diagnostic, of BrS. A type 1 ST-segment elevation, diagnostic of a BrS, was unmasked in leads V1 and V2 with sodium channel blockade using procainamide ( Figure 1 ). ECG characteristics are summarized in Table 2 . PR interval was 180 ms at baseline and increased to 200 ms after procainamide. An internal cardioverter defibrillator was implanted in 2005. The proband was asymptomatic and did not have a family history of sudden cardiac death. Family history was remarkable for a high incidence of cancer. The proband had 2 paternal aunts and 3 paternal uncles, all of whom died of lung cancer. Interrogation of the internal cardioverter defibrillator in July of 2008 revealed an episode of atrial flutter with 2:1 atrioventricular block.
Molecular Genetics
Genetic analysis of 9 Brugada-susceptibility genes (SCN5A, SCN1B, CaCNB2B, CaV1.2, IRX5, KCNE2, KCNE3, KCNE4, and GPD1L) proved negative. Further genetic screening of the sodium channel ␤-subunits revealed a novel missense mutation in exon 1 of SCN3B. Polymerase chain reaction-based sequencing analysis revealed a double peak in the sequence of exon 1 of the SCN3B gene ( Figure 2A) showing a T-to-C transversion at nucleotide 29 (arrow), predicting a leucine (L) to proline (P) substitution at residue 10 (designated L10P). This nucleotide change was not observed in 360 white, 120 Turkish, and 112 Sephardic Jews reference alleles, suggesting that this variation is rare in the general population. Leu-10 is located in the extracellular domain of SCN3B ( Figure 2B ) and is highly conserved through evolution ( Figure 2C ). The only family member available for the study was an unaffected brother whose ECG was normal except for right bundle branch block. The brother was negative for the L10P SCN3B mutation. The proband was the only case in our series of 179 BrS probands with a mutation in SCN3B. One hundred twenty-nine of the 179 probands (72.07%) tested negative for all genes tested.
Electrophysiological Characteristics of SCN5A Coexpressed With WT and Mutant SCN3B in TSA201 Cells
SCN5A/WTϩSCN1B/WT, SCN5A/WTϩSCN1B/WTϩSCN3B/ WT, or SCN5A/WTϩSCN1B/WTϩSCN3B/L10P were ex- pressed in TSA201 cells to assess the effects of the mutation on sodium channel function. Figure 3A shows macroscopic currents recorded from these channels together with the currentvoltage relationships. Maximum peak inward current occurred at a potential of Ϫ35 mV for all channel types. Coexpression of SCN3B/WT with SCN5A/WTϩSCN1B/WT increased peak current density from Ϫ281.3Ϯ62.3 pA/pF to Ϫ402.8Ϯ93.2 pA/pF (nϭ9 and 13, respectively; PϽ0.05 between 2 groups). Coexpression of SCN3B/L10P resulted in a marked decrease in peak sodium current density to Ϫ70.2Ϯ14.5 pA/pF (nϭ25; 17.4% of SCN5A/WTϩSCN1B/ WTϩSCN3B/WT and 25.0% of SCN5A/WTϩSCN1B/WT current density; PϽ0.05 for each; Figure 3B ). Coexpression of SCN3B/L10P produced total loss of function in 40% of cells studied (10 of 25 cells, Figure 3A) . The half-inactivation voltage (V 1/2 ) of mutant I Na channels (SCN5A/WTϩSCN1B/WTϩSCN3B/L10P) was 14.8 and 9.6 mV more negative than those of SCN5A/WTϩSCN1B/WT and SCN5A/WTϩSCN1B/WTϩSCN3B/WT channels, respectively (PϽ0.01, respectively; Table 3 and Figure 4B ). Steadystate activation, obtained after applying the step protocol in inset of Figure 3A , was similar among the 3 groups ( Figure 4B ). Recovery from inactivation, measured using a standard doublepaired pulse protocol, was similar in the 2 control groups but slower in the mutant channels (PϽ0.01, respectively; Table 3 and Figure 4C ). The L10P mutation caused a shift in the voltage dependence of steady-state inactivation and slowed recovery from inactivation, thus serving to further reduce sodium channel availability.
Trafficking of SCN5A Coexpressed With SCN3B/L10P Mutant in TSA201 Cells
To evaluate whether the loss of function caused by the SCN3B/L10P mutation is due in part to a trafficking defect, we studied GFP-fusion-SCN5A/WT coexpressed with SCN1B/WT alone, or combined with either SCN3B/WT or SCN3B/L10P. xyz scans of SCN5A/WTϩSCN1B/WT on the confocal microscope revealed both a central and peripheral pattern of staining suggesting localization of the channel in the cell membrane and intracellular organelles ( Figure 5A through 5C ). Protein expression of SCN5A/WT channels was enhanced when both SCN1B/WT and SCN3B/WT were added ( Figure 5D through 5F). In contrast, SCN3B/L10P resulted in internal staining consistent with intracellular compartmentalization with no evidence of plasma-member staining ( Figure 5G through 5I ), suggesting that channels were trapped in the endoplasmic reticulum and/or Golgi complex. The ratio of peripheral to total cell area fluorescence intensity was similar for SCN5A/ Figure 3 . Effect of SCN3B mutation on sodium channel current recorded in TSA201 cells. A, Representative sodium current traces in TSA201 cells expressing SCN5A/WTϩSCN1B/WT alone or cotransfected with SCN3B/WT or SCN3B/ L10P. All were recorded 48 hours after transfection.
Upper right and left panel shows WT of SCN5AϩSCN1B and SCN5AϩSCN1BϩSCN3B. Two SCN3B/L10P traces are shown in the lower grouping, 1 in which there was partial loss of function (1) and another in which there was total loss of function (2) . The inset shows the voltage-clamp protocol employed. B, Current-voltage relationship for SCN5A/WTϩ SCN1B/WT (nϭ9), SCN5A/WTϩSCN1B/ WTϩSCN3B/WT (nϭ13), and SCN5A/WTϩ SCN1B/WTϩSCN3B/L10P (nϭ25) current density. Peak current density was significantly reduced for SCN5A/WTϩSCN1B/WTϩSCN3B/ L10P when compared with SCN5A/WTϩ SCN1B/WT and SCN5A/WTϩSCN1B/ WTϩSCN3B/WT (values are meanϮSEM; PϽ0.01 for each).
WTϩSCN1B/WT and SCN5A/WTϩSCN1B/WTϩSCN3B/WT (PϾ0.05), but significantly reduced for the mutant channel (SCN5A/WTϩSCN1B/WTϩSCN3B/L10P; PϽ0.01; Figure 5J ). These results demonstrate that ␤3-subunit mutations can lead to impaired trafficking of the cardiac sodium channel. Figure 6 shows the results of Western blot analysis performed to confirm the presence of Na␤3 in human ventricular myocardium. Anti-human SCN3B antibody detected a unique band in membrane proteins from SCN3B transfected TSA201 cells (positive control) and from 2 human left ventricular myocardial preparations, but not in untransfected TSA201 cells (negative control).
Na v ␤3 Expression in the Human Heart
Discussion
Voltage-gated sodium channels are vital to the function of excitable cells including those comprising the heart. Auxiliary or ␤-subunits are known to provide functional diversity among sodium channels. They do not form the ionconducting pore, but are multifunctional proteins that play critical roles in modulation of channel function, regulation of channel expression levels at the plasma membrane, and cell adhesion. 10 To date, 4 different Na v ß subunits have been Parameters of inactivation and activation were calculated from the Boltzmann function (see Methods section). V 1/2 is the voltage for half-maximal availability or activation and k is the slope factor. Parameters of recovery were fitted to a double exponential function (see Methods). f and s are the time constant for the fast and slow gating modes, respectively, of recovery. Data from Figure 4B and 4C are meansϮSEM. *PϽ0.01 versus SCN5A/WTϩ1B/WTϩ3B/WT. †PϽ0.01 versus SCN5A/WTϩ1B/WT. ‡PϽ0.05 versus SCN5A/WTϩ1B/WTϩ3B/WT. Table 3 . C, Recovery from fast inactivation of WT and L10P mutant channels determined. The 2-pulse protocol is shown in the inset. Fitting to a double-exponential function yielded the time constants as demonstrated in Table 3 . f and s in the L10P group were significantly slower as compared with 2 WT groups. Data are shown as meanϮSEM.
described (SCN1B, SCN2B, SCN3B, and SCN4B), [11] [12] [13] [14] [15] and shown to play a critical role in cell adhesion, signal transduction, channel expression at the plasma membrane, and voltage dependence of channel gating. 16 -19 All are detectable in cardiac tissue. 9 ␤1A, a splice variant of SCN1B, is expressed in embryonic brain and adult heart in rat. 20 The distribution and expression level of sodium channel ␣and ␤-subunits in human and canine hearts has not been not well characterized.
Sodium Channel ␤-Subunits Modulate Sodium Channel in Heart
Because of their significant role in modulating channel expression and function, genes that encode cardiac channel ␤-subunit proteins are attractive candidates for ion channelopathies like BrS. 21 The role of ␤1-subunits have been studied most extensively. ␤1-coexpression has been reported to have no observable effect on SCN5A function, 22, 23 to result in increased sodium current density with no detectable effects on channel kinetics or voltage dependence, 24, 25 to modulate channel sensitivity to lidocaine block with subtle changes in channel kinetics and gating properties 26 as well as to shift the voltage dependence of steady-state inactivation [27] [28] [29] or alter the rate of recovery from inactivation. 29, 30 Previous studies involving coexpression of SCN5A with ␤3 have reported (1) increased current density, a depolarizing shift in the voltage dependence of inactivation, and an increased rate of recovery from inactivation in Xenopus oocytes, 30 or (2) a hyperpolarizing shift of inactivation, slowed recovery from inactivation, and reduced late sodium channel current, without any change in peak current density in Chinese hamster ovary-K1 cells. 29 This study involving Figure 5 . Trafficking of GFP-tagged SCN5A channel proteins. TSA201 cells were transfected with GFP-tagged-SCN5A/WT cotransfected with SCN1B/WT and either SCN3B/WT or SCN3B/L10P. All GFP signals were recorded 48 hours after transfection. Photomicrographs show the phase contrast light transmission image (left), stacked serial confocal fluorescent image (center), and a single fluorescent confocal image from the center of the same TSA201 cell. A through C, SCN1B/WTϩSCN5A/WT-GFP; staining in evident in both the periphery and the center of the cell, suggesting that SCN5A channels are trafficked to the cell membrane. D through F, Cotransfected with SCN1B/WT and SCN3B/WT; expression of SCN5A-GFP channels is enhanced throughout. G through I, Cotransfected with SCN3B/L10P; fluorescence is localized in the perinuclear region of the cell suggesting failure of mutant channels to traffic to the plasma membrane. J, Quantitative analysis of relative level of membrane expression of enhanced GFP-tagged SCN5A in the plasma membrane. Fluorescence intensity of SCN5A staining of the plasma membrane (outermost 2 m) is plotted as a ratio of total cell area fluorescence. The ratio was similar for SCN5A/WTϩSCN1B/WT (nϭ22) and SCN5A/WTϩSCN1B/WTϩSCN3B/WT (nϭ26), but much reduced for SCN5A/ WTϩSCN1B/WTϩSCN3B/L10P (nϭ44). **PϽ0.01, meanϮSEM.
TSA201 cells, shows that coexpression of ␤3 with SCN5A and ␤1 increases peak sodium current density, shifted the voltage dependence of channel availability in a hyperpolarizing direction without significantly changing the voltage dependence of activation or recovery kinetics (Figures 3 and  4 , Table 3 ).
Sodium Channel ␤-Subunits and Arrhythmias
Although mutations in Na v 1 ␣-subunits have been associated with inherited diseases, including LQT3, BrS, progressive conduction disease, and atrial standstill, 31 to date only 2 genes encoding sodium channel ␤-subunits have been associated with human cardiac disease. 7, 32 It has long been appreciated that SCN5A mutations associated with LQTS and BrS are modulated by coexpression of SCN1B. 33 BrS is known to be caused by a reduction in I Na . The role of ␤1-subunits to exacerbate the loss of function produced by R1232W/T1620 mol/L mutations in SCN5A in patients with BrS was demonstrated by Wan et al. 34 Mutations in ␤1-subunits (Na v ␤1 and Na v ␤1b) have recently been shown to be associated with a combined BrS and cardiac conduction disease phenotype in humans. 7 Mutation in ␤4-subunit have been reported to be associated with an increase in late I Na giving rise to the LQT3 variant of the long-QT syndrome. 32 In this study, we provide evidence that SCN3B is a BrS-susceptibility gene. An L10P missense mutation in a highly conserved residue, absent in 240 reference alleles, is shown to produce a major reduction in I Na secondary to both functional and trafficking defects in cardiac sodium channel expression. It is well established that there are 4 fully conserved cysteine residues, labeled C2, C21, C24, and C96 in ß1-and ß3-subunits. 15 The disulfide bonds between C2 and C24, C21 and C96 are believed to correspond to the interaction site for ␣-subunit association. Moreover, the former bond is also responsible for forming the Ig fold for ß1 and ß3, a disruption of which can cause an inherited epilepsy syndrome. Our mutation (L10P) is located near C2, which may affect the interaction of the ß3-subunit with the sodium channel complex, and lead to the phenomenon that we observed. Little is known about cardiac sodium channel ␣and ␤-subunits trafficking in vivo. A study using overexpression of fluorescent-tagged SCN5A, ␤1, and ␤2 in HEK293 cells suggested that SCN5A and ␤2 are transported separately to the plasma membrane whereas SCN5A and ␤1 form a complex in the endoplasmic reticulum that may facilitate plasma membrane trafficking. 35 In PC12 and Chinese hamster ovary-K1/Na v 1.5 cells, enhanced GFP-tagged ⌬extracellular domain (extracellular domain deletion) ␤3 mutant showed internal staining with little plasma membrane staining, and enhanced GFP-tagged ⌬internal cardioverter defibrillator (intracellular domain deletion) ␤3-mutant showed no evidence of surface staining but labeled an internal highly reticulated compartment that suggests endoplasmic reticulum. These results indicate that a mutation in the extracellular domain can impair trafficking of SCN3B to the membrane and that deletion of the intracellular domain totally disrupts trafficking of the ␤-subunit. Our results suggest that WT ␤3 plays a role in facilitating SCN5A transport to the plasma membrane, because a mutation in the extracellular domain of ␤3 is capable of disrupting trafficking of SCN5A to the plasma membrane.
SCN3B and Cancer
An interesting aspect of the family studied was that many family members died of lung cancer. SCN3B levels are upregulated in human cancer cell lines by DNA damaging agents, as well as by overexpression of tumor suppressor p53, a transcription factor that induces growth arrest and/or apoptosis in response to cellular stress. Introduction of the SCN3B gene into T98G and Saos2 cells potently suppressed colony formation, and adenovirus-mediated transfer of SCN3B induced apoptosis when combined with anticancer agents. These results suggest that SCN3B mediates a p53dependent apoptotic pathway and may be a candidate for gene therapy combined with anticancer drugs. 36 A more recent study discovered that SCN3B is a candidate cancer gene, which could affect ion-channel transport. 37 From the above point of view, it is tempting to speculate that the L10P mutation in SCN3B may also promote cancer and thus contribute to death of mutant carriers in this family. This hypothesis remains to be tested.
Limitations of the Study
A genotype-phenotype correlation between the ␤3-mutation and BrS phenotype is hampered by the high incidence of cancer deaths in this family, which may be caused by the same mutation in the ß3-subunit. Only 2 family members were available for study. A native American cohort was not available for the study as a control group.
Another limitation of the present study is the fact that characterization of the SCN3B mutation were carried out in a heterologous mammalian expression system, creating conditions that may be different from those encountered in vivo as far as a contribution of ß2-or ß4-subunits, or other components of the Na channel macromolecular complex. Despite these limitations, the electrophysiological characteristics of Figure 6 . Na v ␤3 expression in human ventricular myocardium. Rabbit anti-human SCN3B antibody detects bands in membrane proteins from SCN3B transfected TSA201 cells (positive control) and from 2 human left ventricular myocardial preparations, but not in untransfected TSA201 cells (negative control).
the mutant channel are concordant with the BrS phenotype, and in combination with the clinical data supports a causal relationship between the L10P mutation in SCN3B and the disease.
Summary and Conclusion
Our results provide evidence in support of the hypothesis that mutations in the SCN3B-encoded Na v ␤3 subunit constitute another pathogenic mechanism responsible for development of the BrS phenotype secondary to a loss of function of cardiac sodium channel current.
